Was asked to review myo rates post vax vs post covid
Using this Nordic study of 23 million
For 16-24 yo males, post vax myo rates were
6 (pfizer-pfizer) to 28 (pfizer-moderna) x
HIGHER than post covid
Males 12-15 had 0 post covid myo cases
See # s in 🧵
jamanetwork.com
Using this Nordic study of 23 million
For 16-24 yo males, post vax myo rates were
6 (pfizer-pfizer) to 28 (pfizer-moderna) x
HIGHER than post covid
Males 12-15 had 0 post covid myo cases
See # s in 🧵
jamanetwork.com
Excess myo/pericarditis events in 28 days for 2 dose regimens in 16-24 yo males
80/million pfizer-pfizer (6x post covid)
380/million pfizer-moderna (28x)
260/million moderna-moderna (19x)
numbers from DK & SE included only cases which were hospitalized
80/million pfizer-pfizer (6x post covid)
380/million pfizer-moderna (28x)
260/million moderna-moderna (19x)
numbers from DK & SE included only cases which were hospitalized
Here are the post covid myocarditis rates
For females post covid there were also 0 cases ages 12-15
3.7/million excess events for females 16-24
myo/peri post 2 dose vax was 47/million post pfizer-moderna &
25/million post moderna-moderna
so vax myo in females:
12.7x higher &
6.8x higher than post covid respectively
3.7/million excess events for females 16-24
myo/peri post 2 dose vax was 47/million post pfizer-moderna &
25/million post moderna-moderna
so vax myo in females:
12.7x higher &
6.8x higher than post covid respectively
I'm stopping here, but re boosters:
Per VSD post booster myo in 16-17 yo males 189/million
cdc.gov Per Kaiser 147/million in males 18-39
ncbi.nlm.nih.gov
so this risk doesn't disappear though covid risk has been diminishing
The end
Per VSD post booster myo in 16-17 yo males 189/million
cdc.gov Per Kaiser 147/million in males 18-39
ncbi.nlm.nih.gov
so this risk doesn't disappear though covid risk has been diminishing
The end
Loading suggestions...